{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T20:18:34Z","timestamp":1783196314123,"version":"3.54.6"},"reference-count":25,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005979","name":"Marc Lustgarten Pancreatic Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005979","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015696","name":"Siemens Healthineers USA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015696","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011699","name":"Siemens Healthineers","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011699","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiology Case Reports"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.radcr.2026.04.076","type":"journal-article","created":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T09:33:24Z","timestamp":1779010404000},"page":"3326-3332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adult-onset neuroblastic tumor: An extremely rare entity in the adult population"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9099-9465","authenticated-orcid":false,"given":"Connor W.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1560-9172","authenticated-orcid":false,"given":"Felipe","family":"Lopez-Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huili","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2567-1658","authenticated-orcid":false,"given":"Elliot K.","family":"Fishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.radcr.2026.04.076_bib0001","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7","article-title":"The International Neuroblastoma Pathology Classification (the Shimada system)","volume":"86","author":"Shimada","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.radcr.2026.04.076_bib0002","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-024-04680-w","article-title":"Emerging trends in neuroblastoma diagnosis, therapeutics, and research","author":"Sharma","year":"2025","journal-title":"Mol Neurobiol"},{"issue":"8","key":"10.1016\/j.radcr.2026.04.076_bib0003","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31074","article-title":"Adolescent- and adult-onset neuroblastic tumor: a retrospective multicenter observational study of patients diagnosed in France between 2000 and 2020","volume":"71","author":"Magnier","year":"2024","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.radcr.2026.04.076_bib0004","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/pbc.20859","article-title":"Neuroblastoma in adults: incidence and survival analysis based on SEER data","volume":"49","author":"Esiashvili","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.radcr.2026.04.076_bib0005","doi-asserted-by":"crossref","first-page":"16078","DOI":"10.1038\/nrdp.2016.78","article-title":"Neuroblastoma","volume":"2","author":"Matthay","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"14","key":"10.1016\/j.radcr.2026.04.076_bib0006","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1002\/cam4.4653","article-title":"Prognostic impact of tumor size on patients with neuroblastoma in a SEER-based study","volume":"11","author":"Wang","year":"2022","journal-title":"Cancer Med"},{"key":"10.1016\/j.radcr.2026.04.076_bib0007","doi-asserted-by":"crossref","first-page":"175030","DOI":"10.1016\/j.ejphar.2022.175030","article-title":"Neuroblastoma: essential genetic pathways and current therapeutic options","volume":"926","author":"Salemi","year":"2022","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.radcr.2026.04.076_bib0008","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/rg.231025050","article-title":"Neurogenic tumors in the abdomen: tumor types and imaging characteristics","volume":"23","author":"Rha","year":"2003","journal-title":"Radiographics"},{"issue":"12","key":"10.1016\/j.radcr.2026.04.076_bib0009","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1093\/neuonc\/noae152","article-title":"Defining neuroblastoma: from origin to precision medicine","volume":"26","author":"Sainero-Alcolado","year":"2024","journal-title":"Neuro Oncol"},{"issue":"5","key":"10.1016\/j.radcr.2026.04.076_bib0010","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/ijc.31399","article-title":"Treatment and outcome of adult-onset neuroblastoma","volume":"143","author":"Suzuki","year":"2018","journal-title":"Int J Cancer"},{"issue":"46","key":"10.1016\/j.radcr.2026.04.076_bib0011","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1038\/s41388-022-02489-2","article-title":"Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism","volume":"41","author":"Watanabe","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.radcr.2026.04.076_bib0012","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines): neuroblastoma. Version 2.2023. Accessed October 23, 2025. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1520."},{"issue":"4","key":"10.1016\/j.radcr.2026.04.076_bib0013","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00247-022-05489-2","article-title":"Imaging in neuroblastoma","volume":"53","author":"Littooij","year":"2023","journal-title":"Pediatr Radiol"},{"issue":"2","key":"10.1016\/j.radcr.2026.04.076_bib0014","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1148\/rg.2018170132","article-title":"Updates in diagnosis, management, and treatment of neuroblastoma","volume":"38","author":"Swift","year":"2018","journal-title":"Radiographics"},{"issue":"2","key":"10.1016\/j.radcr.2026.04.076_bib0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4103\/0971-3026.155844","article-title":"Imaging in neuroblastoma: an update","volume":"25","author":"Kembhavi","year":"2015","journal-title":"Indian J Radiol Imaging"},{"issue":"1","key":"10.1016\/j.radcr.2026.04.076_bib0016","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1102\/1470-7330.2005.0104","article-title":"Neuroblastoma in childhood: review and radiological findings","volume":"5","author":"Papaioannou","year":"2005","journal-title":"Cancer Imaging"},{"issue":"4","key":"10.1016\/j.radcr.2026.04.076_bib0017","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3390\/jpm11040270","article-title":"Nuclear medicine imaging in neuroblastoma: current status and new developments","volume":"11","author":"Samim","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.radcr.2026.04.076_bib0018","unstructured":"International Neuroblastoma Risk Group Task Force. INRG staging system. Accessed October 23, 2025. https:\/\/inrgdb.org\/neuroblastoma-information\/staging-system\/."},{"key":"10.1016\/j.radcr.2026.04.076_bib0019","unstructured":"Park JA, Bagatell R. Epidemiology, pathogenesis, and pathology of neuroblastoma. UpToDate. Accessed October 23, 2025. https:\/\/www.uptodate.com\/contents\/epidemiology-pathogenesis-and-pathology-of-neuroblastoma."},{"issue":"1","key":"10.1016\/j.radcr.2026.04.076_bib0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pcl.2007.10.014","article-title":"Neuroblastoma: biology, prognosis, and treatment","volume":"55","author":"Park","year":"2008","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.radcr.2026.04.076_bib0021","unstructured":"Perrino C, Zynger DL, Tretiakova M. Neuroblastoma. PathologyOutlines.Com. Accessed October 23, 2025. https:\/\/www.pathologyoutlines.com\/topic\/adrenalneuroblastoma.html."},{"key":"10.1016\/j.radcr.2026.04.076_bib0022","series-title":"Clinical applications of mass spectrometry in drug analysis: methods and protocols","first-page":"185","article-title":"Quantitation of neuroblastoma markers homovanillic acid (HVA) and vanillylmandelic acid (VMA) in urine by gas chromatography-mass spectrometry (GC\/MS)","author":"Beals","year":"2022"},{"key":"10.1016\/j.radcr.2026.04.076_bib0023","unstructured":"American Cancer Society. Chemotherapy and related drugs for neuroblastoma. Accessed October 23, 2025. https:\/\/www.cancer.org\/cancer\/types\/neuroblastoma\/treating\/chemotherapy.html."},{"issue":"10","key":"10.1016\/j.radcr.2026.04.076_bib0024","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/14737140.2017.1364995","article-title":"Anti-GD2 immunotherapy for neuroblastoma","volume":"17","author":"Sait","year":"2017","journal-title":"Expert Rev Anticancer Ther"},{"issue":"10","key":"10.1016\/j.radcr.2026.04.076_bib0025","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.3390\/ijms26104722","article-title":"Targeting pathways in neuroblastoma: advances in treatment strategies and clinical outcomes","volume":"26","author":"Benchia","year":"2025","journal-title":"Int J Mol Sci"}],"container-title":["Radiology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1930043326003316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1930043326003316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T20:00:04Z","timestamp":1783195204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1930043326003316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1930043326003316"],"URL":"https:\/\/doi.org\/10.1016\/j.radcr.2026.04.076","relation":{},"ISSN":["1930-0433"],"issn-type":[{"value":"1930-0433","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adult-onset neuroblastic tumor: An extremely rare entity in the adult population","name":"articletitle","label":"Article Title"},{"value":"Radiology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radcr.2026.04.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of University of Washington.","name":"copyright","label":"Copyright"}]}}